Delivery Order HHSN261201600019I-HHSN26100003
- This is a Cost Plus Fixed Fee delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Battelle Memorial Institute, a non-profit organization and manufacturer of goods. The contract is for an exploratory toxicology study in dogs of an MCL-1 inhibitor drug being developed for cancer and other diseases. The contract has a potential value of $116,039 and a completion date of June 30, 2021. It is a task...
- This is a $631,772.00 delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for toxicology studies on reproductive effects in rats, supporting the NCCIH (National Center for Complementary and Integrative Health) program. This is a cost-plus-fixed-fee contract that was not set aside for any type of small...
- This is a delivery order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to IIT Research Institute, a non-profit research organization, for a series of toxicology studies in rabbits for drugs developed for cancer patients. The $487,537.00 contract is part of the Toxicology of Drugs Developed for Cancer Patients indefinite delivery/indefinite quantity contract vehicle and includes dose range finding, preliminary embryo fetal...
- <p>This is a $1,784.00 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency, to Battelle Memorial Institute for initial administrative charges related to a pre-clinical toxicology study of a drug being developed for cancer patients. The contract is an order placed under the Toxicology of Drugs Developed for Cancer Patients indefinite-delivery indefinite-quantity (IDIQ) contract vehicle. No set-aside was used for this award.</p>
- This is a $1,886,133.00 Cost Plus Fixed Fee delivery order contract awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a division of the Illinois Institute of Technology (IIT), to conduct toxicology studies in rats and dogs administered the drug candidate AIT-102. The contract has an ultimate completion date of March 31, 2026. IITRI is a non-profit contract research organization that specializes in preclinical drug development services for federal agencies,...
- This is a definitive contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to the University of Illinois for preclinical pharmacology and toxicology studies. The contract, valued at $24,207,156.38, does not have a set-aside designation. The University of Illinois, a major public research institution, is conducting research and development work to support the PREVENT Cancer Preclinical Drug Development Program, a structured...
- This is a $1,790,042.00 Delivery Order Contract awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit subsidiary of the Illinois Institute of Technology (IIT). The contract is for toxicology studies in mice and dogs administered MTX-531, which does not have a set-aside designation. IITRI is a leading preclinical contract research organization that specializes in providing drug development services to federal agencies like the NCI, NIAID, NINDS, and...
- This is a $1,010.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for a "Kick Off Meeting, Preclinical Pharmacokinetic & Pharmacology Evaluations of Agents Being Developed for Cancer Patients" with a performance period from July 1, 2016 to September 30, 2016. This work is being performed under NCI's Pharmacokinetic and Pharmacology Evaluations for...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $4,145 contract is for a pre-clinical toxicology study of a drug developed for cancer patients, as part of the Toxicology of Drugs Developed for Cancer Patients contract vehicle. IITRI specializes in preclinical drug development services and has...
- This is a $718,265.00 delivery order awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to IIT Research Institute, the research and technology development arm of Illinois Institute of Technology (IIT). The contract supports preclinical toxicology and pharmacology research for drugs developed for cancer patients, including exploratory studies of CCR4 CAR T cells. This work is performed under the NCI's "Toxicology of Drugs Developed for...
- HHSN261201600019IIndefinite Delivery Contract
- HHSN261201600019I-HHSN26100003Delivery Order
This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to the University of Illinois. The contract is valued at $761,043.02 and is part of the larger "Toxicology of Drugs Developed for Cancer Patients" indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The purpose of this award is to conduct pre-clinical toxicology studies of a drug candidate, specifically DNA methyltransferase-TdCyd, for potential use in cancer treatment. The studies will be conducted on rats and dogs, with funding of $234,760 for the rat study and $478,298 for the dog study. The contract has an ultimate completion date of August 31, 2017. There was no set-aside designation used for this award.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
PRECLINICAL TOXICOLOGY OF DRUGS DEVELOPED FOR CANCER PATIENTS | N02CM47001-42 | Department of Health and Human Services National Institutes of Health | Award Notice 1/2 | 4/4/14, 1:44 PM | |
PRECLINICAL TOXICOLOGY OF DRUGS DEVELOPED FOR CANCER PATIENTS | N02CM47001-42 | Department of Health and Human Services National Institutes of Health | Award Notice 2/2 | 7/6/16, 4:04 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($38) | 4/28/21 | |
| 1 | Change Order | $48.0k | 12/16/16 | |
| Not listed | Not listed | $713.1k | 9/1/16 |